Evidence for changing lipid management strategy to focus on non-high density lipoprotein cholesterol

Risk of incident atherosclerotic cardiovascular disease events by achieved atherogenic lipid levels among 62,428 statin-treated individuals with diabetes mellitus

(2018) Jamal S. Rana et al.   AMERICAN JOURNAL OF CARDIOLOGY

Non-HDL-C goals based on the distribution of population percentiles in ELSA-Brasil: Is it time to change?

(2018) Fabiano A. Brito et al.   ATHEROSCLEROSIS

Non-HDL-C levels and residual cardiovascular risk: Do population-specific precision approaches offer any advantages?

(2018) Byambaa Enkhmaa et al.   ATHEROSCLEROSIS

Residual Inflammatory Risk on Treatment With PCSK9 Inhibition and Statin Therapy

(2018) Aruna D. Pradhan et al.   CIRCULATION

On-treatment lipid profiles to predict the cardiovascular outcomes in ASCVD patients comorbid with chronic kidney disease – The multi-center T-SPARCLE registry study

(2018) Li-Ting Ho et al.   JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION

Impact of 3-year changes in lipid parameters and their ratios on incident type 2 diabetes: Tehran lipid and glucose study

(2018) Pegah Khaloo et al.   Nutrition & Metabolism

Combination Lipid-Lowering Therapies for the Prevention of Recurrent Cardiovascular Events

(2018) Sara Lee et al.   Current Cardiology Reports

Familial hypercholesterolemia treatments: Guidelines and new therapies

(2018) Frederick J. Raal et al.   ATHEROSCLEROSIS

Increased Residual Cardiovascular Risk in Patients with Diabetes and High vs. Normal Triglycerides Despite Statin-Controlled LDL Cholesterol

(2018) Gregory A. Nichols et al.   DIABETES OBESITY & METABOLISM

Effect of visit-to-visit LDL-, HDL-, and non-HDL-cholesterol variability on mortality and cardiovascular outcomes after percutaneous coronary intervention

(2018) Eun Young Lee et al.   ATHEROSCLEROSIS

Non-high-density lipoprotein cholesterol and risk of cardiovascular disease in the general population and patients with type 2 diabetes: A systematic review and meta-analysis

(2018) Yanchao Cao et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Efficacy and Safety of Adding Ezetimibe to Statin Therapy Among Women and Men: Insight From IMPROVE‐IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)

(2017) Eri Toda Kato et al.   Journal of the American Heart Association

Atherogenic Lipoprotein Determinants of Cardiovascular Disease and Residual Risk Among Individuals With Low Low‐Density Lipoprotein Cholesterol

(2017) Patrick R. Lawler et al.   Journal of the American Heart Association

2016 ESC/EAS Guidelines for the Management of Dyslipidaemias

(2016) Alberico L. Catapano et al.   ATHEROSCLEROSIS

2016 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult

(2016) Todd J. Anderson et al.   CANADIAN JOURNAL OF CARDIOLOGY

New Cholesterol Guidelines for the Management of Atherosclerotic Cardiovascular Disease Risk

(2016) Bhavin B. Adhyaru et al.   ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA

Non-HDL-C is a Better Predictor for the Severity of Coronary Atherosclerosis Compared with LDL-C

(2016) Yan Zhang et al.   Heart Lung and Circulation

Relationship between Non-High-Density Lipoprotein Cholesterol and Low-Density Lipoprotein Cholesterol in the General Population:

(2016) Kazuyo Kuwabara et al.   Journal of Atherosclerosis and Thrombosis

Non–high-density lipoprotein cholesterol target achievement in patients on lipid-lowering drugs and stratified by triglyceride levels in the Arabian Gulf

(2016) Khamis Al-Hashmi et al.   Journal of Clinical Lipidology

Cause-specific mortality for 240 causes in China during 1990–2013: a systematic subnational analysis for the Global Burden of Disease Study 2013

(2016) Maigeng Zhou et al.   LANCET

Age- and sex-related changes in fasting plasma glucose and lipoprotein in cynomolgus monkeys

(2016) Feng Yue et al.   Lipids in Health and Disease

Relationship of the triglyceride to high-density lipoprotein cholesterol (TG/HDL-C) ratio to the remainder of the lipid profile: The Very Large Database of Lipids-4 (VLDL-4) study

(2015) Renato Quispe et al.   ATHEROSCLEROSIS

Patient-Level Discordance in Population Percentiles of the Total Cholesterol to High-Density Lipoprotein Cholesterol Ratio in Comparison With Low-Density Lipoprotein Cholesterol and Non–High-Density Lipoprotein CholesterolCLINICAL PERSPECTIVE

(2015) Mohamed B. Elshazly et al.   CIRCULATION

Effects of add-on lipid-modifying therapy on top of background statin treatment on major cardiovascular events: A meta-analysis of randomized controlled trials

(2015) Chi-kin Ip et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Serum Lipid Goal Attainment in Chronic Kidney Disease (CKD) Patients under the Japan Atherosclerosis Society (JAS) 2012 Guidelines

(2015) Rumiko Shimizu et al.   Journal of Atherosclerosis and Thrombosis

Proof That Lower Is Better — LDL Cholesterol and IMPROVE-IT

(2015) John A. Jarcho et al.   NEW ENGLAND JOURNAL OF MEDICINE

Clinical- and cost-effectiveness of LDL particle-guided statin therapy: A simulation study

(2014) Henry J. Folse et al.   ATHEROSCLEROSIS

Lipid modification and cardiovascular risk assessment for the primary and secondary prevention of cardiovascular disease: summary of updated NICE guidance

(2014) S. Rabar et al.   BMJ-British Medical Journal

Discordance between non-HDL-cholesterol and LDL-particle measurements: Results from the Multi-Ethnic Study of Atherosclerosis

(2013) Emil M. deGoma et al.   ATHEROSCLEROSIS

2012 Update of the Canadian Cardiovascular Society Guidelines for the Diagnosis and Treatment of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult

(2013) Todd J. Anderson et al.   CANADIAN JOURNAL OF CARDIOLOGY

Diagnosis and treatment of familial hypercholesterolaemia

(2013) G. Kees Hovingh et al.   EUROPEAN HEART JOURNAL

Non-HDL cholesterol vs. Apo B for risk of coronary heart disease in healthy individuals: the EPIC-Norfolk prospective population study

(2013) Brigitte M. Sondermeijer et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

A Review of Lipid Management in Primary and Secondary Prevention

(2013) Ewa Dembowski et al.   Journal of Cardiopulmonary Rehabilitation and Prevention

An International Atherosclerosis Society Position Paper: Global recommendations for the management of dyslipidemia

(2013) Scott M. Grundy   Journal of Clinical Lipidology

Non–High-Density Lipoprotein Cholesterol, Guideline Targets, and Population Percentiles for Secondary Prevention in 1.3 Million Adults

(2013) Mohamed B. Elshazly et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults

(2013) Neil J. Stone et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Alteration of Relation of Atherogenic Lipoprotein Cholesterol to Apolipoprotein B by Intensive Statin Therapy in Patients With Acute Coronary Syndrome (from the Limiting UNdertreatment of lipids in ACS With Rosuvastatin [LUNAR] Trial)

(2012) Christie M. Ballantyne et al.   AMERICAN JOURNAL OF CARDIOLOGY

The effect of rosuvastatin on incident pneumonia: results from the JUPITER trial

(2012) V. Novack et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

Lipids and Lipoproteins and Risk of Different Vascular Events in the MRC/BHF Heart Protection Study

(2012) Sarah Parish et al.   CIRCULATION

Association of LDL Cholesterol, Non–HDL Cholesterol, and Apolipoprotein B Levels With Risk of Cardiovascular Events Among Patients Treated With Statins

(2012) S. Matthijs Boekholdt et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Assessment of adiponectin and the risk of recurrent cardiovascular events in patients presenting with an acute coronary syndrome: Observations from the Pravastatin Or atorVastatin Evaluation and Infection Trial–Thrombolysis in Myocardial Infarction 22 (PROVE IT–TIMI 22)

(2011) Sean R. Wilson et al.   AMERICAN HEART JOURNAL

2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult – 2009 recommendations

(2011) Jacques Genest et al.   CANADIAN JOURNAL OF CARDIOLOGY

Reliability of low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B measurement

(2011) John H. Contois et al.   Journal of Clinical Lipidology

Non–High-Density Lipoprotein Cholesterol Versus Apolipoprotein B in Cardiovascular Risk Stratification

(2011) Vimal Ramjee et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Semi-parametric risk prediction models for recurrent cardiovascular events in the LIPID study

(2010) Jisheng Cui et al.   BMC Medical Research Methodology

Apolipoprotein B and Cardiovascular Disease Risk: Position Statement from the AACC Lipoproteins and Vascular Diseases Division Working Group on Best Practices

(2009) J. H. Contois et al.   CLINICAL CHEMISTRY

From 4S to IDEAL: the health economics of the statin trials

(2009) Peter Lindgren et al.   EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION

Meta-Analysis of the Relationship Between Non–High-Density Lipoprotein Cholesterol Reduction and Coronary Heart Disease Risk

(2009) Jennifer G. Robinson et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Lipids, Apolipoproteins, and Their Ratios in Relation to Cardiovascular Events With Statin Treatment

(2008) John J.P. Kastelein et al.   CIRCULATION

Coronary heart disease in China

(2008) X-H Zhang et al.   HEART

The importance of non–HDL cholesterol reporting in lipid management

(2008) Michael J. Blaha et al.   Journal of Clinical Lipidology

Association of the Trp719Arg Polymorphism in Kinesin-Like Protein 6 With Myocardial Infarction and Coronary Heart Disease in 2 Prospective Trials

(2008) Olga A. Iakoubova et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Impact of Triglyceride Levels Beyond Low-Density Lipoprotein Cholesterol After Acute Coronary Syndrome in the PROVE IT-TIMI 22 Trial

(2008) Michael Miller et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY